We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+1.44%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$433M
AUM Growth
+$33.6M
Cap. Flow
+$30.1M
Cap. Flow %
6.97%
Top 10 Hldgs %
35.53%
Holding
194
New
33
Increased
45
Reduced
29
Closed
6

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$10.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.48M
3
PE
PARSLEY ENERGY INC
PE
+$4.25M
4
CELG
Celgene Corp
CELG
+$3.67M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.26M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$743K
2
AAPL icon
Apple
AAPL
+$533K
3
GE icon
GE Aerospace
GE
+$437K
4
GS icon
Goldman Sachs
GS
+$424K
5
MMM icon
3M
MMM
+$187K

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Financials 16.86%
3 Technology 16.26%
4 Energy 11.68%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNV icon
126
Franco-Nevada
FNV
$46.5B
$76K 0.02%
1,000
– –
ECL icon
127
Ecolab
ECL
$79.7B
$71K 0.02%
+600
New +$69.9K
SBUX icon
128
Starbucks
SBUX
$119B
$71K 0.02%
1,240
+540
+77% +$30.7K
MLI icon
129
Mueller Industries
MLI
$15.2B
$70K 0.02%
+8,800
New +$68K
DD
130
DELISTED
Du Pont De Nemours E I
DD
$69K 0.02%
1,055
+1,000
+1,818% +$65.7K
SNR
131
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$62K 0.01%
5,866
– –
TG icon
132
Tredegar Corp
TG
$292M
$57K 0.01%
3,535
– –
MCK icon
133
McKesson
MCK
$103B
$56K 0.01%
+300
New +$52.6K
REGN icon
134
Regeneron Pharmaceuticals
REGN
$83.2B
$52K 0.01%
+150
New +$57.8K
EPC icon
135
Edgewell Personal Care
EPC
$1.29B
$51K 0.01%
+600
New +$48.5K
JPM.PRH
136
DELISTED
JPMorgan Chase & Co.
JPM.PRH
$51K 0.01%
1,900
– –
CB icon
137
Chubb
CB
$134B
$49K 0.01%
+375
New +$46.2K
TXT icon
138
Textron
TXT
$15.3B
$48K 0.01%
+1,300
New +$49.5K
EIX icon
139
Edison International
EIX
$26.1B
$47K 0.01%
600
– –
WFC.PRJ.CL
140
DELISTED
Wells Fargo & Company
WFC.PRJ.CL
$47K 0.01%
1,700
– –
LGF
141
DELISTED
Lions Gate Entertainment
LGF
$47K 0.01%
+2,300
New +$48.2K
CTSH icon
142
Cognizant
CTSH
$26.3B
$43K 0.01%
+750
New +$45.3K
AEP icon
143
American Electric Power
AEP
$66.9B
$42K 0.01%
600
– –
LOW icon
144
Lowe's Companies
LOW
$123B
$39K 0.01%
+488
New +$37.7K
MOS icon
145
The Mosaic Company
MOS
$7.46B
$39K 0.01%
1,500
– –
ANSS
146
DELISTED
Ansys
ANSS
$36K 0.01%
+400
New +$35.4K
AXP icon
147
American Express
AXP
$229B
$36K 0.01%
600
– –
PNY
148
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$36K 0.01%
600
– –
GG
149
DELISTED
Goldcorp Inc
GG
$34K 0.01%
1,800
– –
HSIC icon
150
Henry Schein
HSIC
$9.82B
$33K 0.01%
+479
New +$32.4K
4 5
6
7 8

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Kelly Lawrence W & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Kelly Lawrence W & Associates held 194 positions worth $433M, up 8.4% from $399M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Kelly Lawrence W & Associates deployed $30.1M of net new capital in Q2 2016, opening 33 new positions and adding to 45 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was American International, an estimated $743K trimmed.

  • Kelly Lawrence W & Associates's largest Q2 2016 buy was Vertex Pharmaceuticals: 98,185 shares worth $8.45M.
  • Kelly Lawrence W & Associates added most to Allergan plc in Q2 2016, an estimated $10.3M increase.
  • Kelly Lawrence W & Associates's biggest Q2 2016 reduction was American International, cutting an estimated $743K.
  • Kelly Lawrence W & Associates fully exited Marsh in Q2 2016, selling an estimated $103K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 36% of its $433M portfolio in Q2 2016.
  • Kelly Lawrence W & Associates opened 33 new positions and closed 6 in Q2 2016.
  • Kelly Lawrence W & Associates's portfolio value rose 8.4% quarter-over-quarter to $433M.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.